Skip to main content
. 2014 Apr 1;53(15):2494–2504. doi: 10.1021/bi500183c

Table 2. Orbitrap MS/MS Analysis of Modified Peptides Derived from GlgE after Exposure to 2-Deoxy-2-fluoro-α-maltosyl Fluoride.

E423A S. coelicolor GlgE
  R392a V D*b N P H T K P V A F403
b-ions 157.10 256.17 697.30 811.34 908.40 1045.45 1146.50 1274.60 1371.65 1470.72 1541.76
y-ions 1550.73 1451.67 1010.54 896.49 779.44 662.38 561.33 433.24 336.19 237.12 166.08
M. tuberculosis GlgE
  F415a R V D*b N P H T K P P N F427
b-ions 148.07 304.17 403.24 844.37 958.41 1055.46 1192.52 1293.57 1421.67 1518.72 1615.77 1729.81
y-ions 1747.82 1591.72 1492.66 1051.53 937.48 840.43 703.37 602.32 474.23 377.18 280.12 166.08
a

The peptide was sequenced by assignment of the m/z of singly charged b-ions and y-ions.

b

D* denotes the modified residue with an observed mass change within the b-ion series of 441.13 Da in both cases that was consistent with the predicted value (115.03 Da for the Asp plus 326.10 Da for the 2-deoxy-2-fluoromaltosyl group, giving 441.16 Da).